ERF — Eurofins Scientific SE Share Price
Last trade - 00:00- €9.26bn
- €12.30bn
- €6.95bn
- 96
- 44
- 92
- 93
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 13.5 | ||
| PEG Ratio (f) | 3 | ||
| EPS Growth (f) | 4.71% | ||
| Dividend Yield (f) | 1.47% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.73 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 11.71 | ||
| Price to Sales | 1.33 | ||
| EV to EBITDA | 7.62 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 11.58% | ||
| Return on Equity | 12.18% | ||
| Operating Margin | 14.63% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 5,438.8 | 6,717.7 | 6,712.1 | 6,514.6 | 6,951 | 7,415.4 | 7,894.93 | 8.78% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +105.49 | +46.56 | -30.14 | -17.06 | +20.09 | +0.79 | +13.87 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Eurofins Scientific SE is a Luxembourg-based company engaged in the business support services industry. The Company joins a part of international group of laboratories providing a range of analytical testing services to the pharmaceutical, food, environmental and, consumer products industries and to governments. It operates through a number of subsidiaries, such as VRL Laboratories in the United States, Institut Nehring GmbH in Germany, Agfirst Bay of Plenty, a fruit maturity testing laboratory in New Zealand, and Megalab SA, a clinical diagnostic laboratory in Spain.
Directors
- Gilles Martin CHM (58)
- Valerie Hanote EDR (55)
- Yves-Loic Martin EDR (55)
- Stuart Anthony Anderson NID (79)
- Patrizia Luchetta NID (57)
- Fereshteh Pouchantchi NID (67)
- Pascal Rakovsky NID (62)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 30th, 2012
- Public Since
- October 24th, 1997
- No. of Employees
- 62,696
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 186,781,812
- Address
- 23 val Fleuri, LUXEMBOURG, 1526
- Web
- https://www.eurofins.com/
- Phone
- Auditors
- deloitte audit societe a responsabilite limitee
Latest News for ERF
Upcoming Events for ERF
Q1 2025 Eurofins Scientific SE Trading Statement Release
Q1 2025 Eurofins Scientific SE Trading Statement Call
Eurofins Scientific SE Extraordinary Shareholders Meeting
Eurofins Scientific SE Annual Shareholders Meeting
Half Year 2025 Eurofins Scientific SE Earnings Release
Similar to ERF
Abionyx Pharma SA
Euronext - Paris
Abivax SA
Euronext - Paris
Adocia SA
Euronext - Paris
Biophytis SA
Euronext - Paris
Cellectis SA
Euronext - Paris
FAQ
As of Today at 20:32 UTC, shares in Eurofins Scientific SE are trading at €49.57. This share price information is delayed by 15 minutes.
Shares in Eurofins Scientific SE last closed at €49.57 and the price had moved by -15.87% over the past 365 days. In terms of relative price strength the Eurofins Scientific SE share price has underperformed the FTSE Global All Cap Index by -17.35% over the past year.
The overall consensus recommendation for Eurofins Scientific SE is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Eurofins Scientific SE dividend yield is 1.21% based on the trailing twelve month period.
Last year, Eurofins Scientific SE paid a total dividend of €0.60, and it currently has a trailing dividend yield of 1.21%. We do not have any data on when Eurofins Scientific SE is to next pay dividends.
We do not have data on when Eurofins Scientific SE is to next pay dividends. The historic dividend yield on Eurofins Scientific SE shares is currently 1.21%.
To buy shares in Eurofins Scientific SE you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €49.57, shares in Eurofins Scientific SE had a market capitalisation of €9.26bn.
Here are the trading details for Eurofins Scientific SE:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ERF
Based on an overall assessment of its quality, value and momentum Eurofins Scientific SE is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Eurofins Scientific SE is €58.40. That is 17.81% above the last closing price of €49.57.
Analysts covering Eurofins Scientific SE currently have a consensus Earnings Per Share (EPS) forecast of €3.53 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Eurofins Scientific SE. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -9.88%.
As of the last closing price of €49.57, shares in Eurofins Scientific SE were trading -0.95% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Eurofins Scientific SE PE ratio based on its reported earnings over the past 12 months is 13.5. The shares last closed at €49.57.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Eurofins Scientific SE's management team is headed by:
- Gilles Martin - CHM
- Valerie Hanote - EDR
- Yves-Loic Martin - EDR
- Stuart Anthony Anderson - NID
- Patrizia Luchetta - NID
- Fereshteh Pouchantchi - NID
- Pascal Rakovsky - NID